248 related articles for article (PubMed ID: 26219930)
1. Identification of intranuclear inclusions is useful for the cytological diagnosis of ovarian clear cell carcinoma.
Naka M; Ohishi Y; Kaku T; Watanabe S; Tamiya S; Ookubo F; Kato K; Oda Y; Sugishima S
Diagn Cytopathol; 2015 Nov; 43(11):879-84. PubMed ID: 26219930
[TBL] [Abstract][Full Text] [Related]
2. [Cytology of ovarian epithelial tumors].
Otsuki T; Yaegashi N
Nihon Rinsho; 2004 Oct; 62 Suppl 10():503-6. PubMed ID: 15535296
[No Abstract] [Full Text] [Related]
3. [Pathological diagnosis of ovarian cancer].
Yamabe H
Nihon Rinsho; 2004 Oct; 62 Suppl 10():507-10. PubMed ID: 15535297
[No Abstract] [Full Text] [Related]
4. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
[TBL] [Abstract][Full Text] [Related]
5. Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma.
Takaya A; Peng WX; Ishino K; Kudo M; Yamamoto T; Wada R; Takeshita T; Naito Z
Int J Oncol; 2015 Apr; 46(4):1573-81. PubMed ID: 25633807
[TBL] [Abstract][Full Text] [Related]
6. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.
Higashiguchi A; Yamada T; Susumu N; Mori T; Suzuki A; Aoki D; Sakamoto M
Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029
[TBL] [Abstract][Full Text] [Related]
7. The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes.
Lu L; Wang S; Zhu Q; Qu Y; Gu W; Ning Y; Chen X; Wang Y
Pathol Res Pract; 2018 Aug; 214(8):1087-1094. PubMed ID: 29866423
[TBL] [Abstract][Full Text] [Related]
8. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
9. Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.
Mackenzie R; Talhouk A; Eshragh S; Lau S; Cheung D; Chow C; Le N; Cook LS; Wilkinson N; McDermott J; Singh N; Kommoss F; Pfisterer J; Huntsman DG; Köbel M; Kommoss S; Gilks CB; Anglesio MS
Am J Surg Pathol; 2015 Nov; 39(11):1548-57. PubMed ID: 26099008
[TBL] [Abstract][Full Text] [Related]
10. Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
Uehara Y; Oda K; Ikeda Y; Koso T; Tsuji S; Yamamoto S; Asada K; Sone K; Kurikawa R; Makii C; Hagiwara O; Tanikawa M; Maeda D; Hasegawa K; Nakagawa S; Wada-Hiraike O; Kawana K; Fukayama M; Fujiwara K; Yano T; Osuga Y; Fujii T; Aburatani H
PLoS One; 2015; 10(6):e0128066. PubMed ID: 26043110
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma.
Lim D; Ip PP; Cheung AN; Kiyokawa T; Oliva E
Am J Surg Pathol; 2015 Aug; 39(8):1061-9. PubMed ID: 25871622
[TBL] [Abstract][Full Text] [Related]
12. Cytologic study of ascites and the endometrium in ovarian carcinoma. Clinical significance.
Hirasawa T; Yasuda M; Muramatsu T; Itoh H; Shinozuka T; Makino T; Tsutsumi Y; Osamura RY
Acta Cytol; 1997; 41(5):1451-5. PubMed ID: 9305383
[TBL] [Abstract][Full Text] [Related]
13. Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.
Kuo KT; Mao TL; Jones S; Veras E; Ayhan A; Wang TL; Glas R; Slamon D; Velculescu VE; Kuman RJ; Shih IeM
Am J Pathol; 2009 May; 174(5):1597-601. PubMed ID: 19349352
[TBL] [Abstract][Full Text] [Related]
14. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics.
Prat J; D'Angelo E; Espinosa I
Hum Pathol; 2018 Oct; 80():11-27. PubMed ID: 29944973
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary.
Morioka S; Kawaguchi R; Yamada Y; Iwai K; Yoshimoto C; Kobayashi H
J Ovarian Res; 2019 Feb; 12(1):20. PubMed ID: 30803452
[TBL] [Abstract][Full Text] [Related]
16. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.
Kao YC; Lin MC; Lin WC; Jeng YM; Mao TL
Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504
[TBL] [Abstract][Full Text] [Related]
17. A comparative analysis of MRI findings in endometrial cancer: differentiation between endometrioid adenocarcinoma, serous carcinoma, and clear cell carcinoma.
Mori T; Kato H; Kawaguchi M; Hatano Y; Ishihara T; Noda Y; Hyodo F; Matsuo M; Furui T; Morishige KI
Eur Radiol; 2022 Jun; 32(6):4128-4136. PubMed ID: 35061079
[TBL] [Abstract][Full Text] [Related]
18. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.
Han G; Gilks CB; Leung S; Ewanowich CA; Irving JA; Longacre TA; Soslow RA
Am J Surg Pathol; 2008 Jul; 32(7):955-64. PubMed ID: 18460981
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative cytology of clear cell carcinoma of the ovary.
Vrdoljak-Mozetic D; Stanković T; Krasević M; Versa-Ostojić D; Stemberger-Papić S; Rupcić S
Cytopathology; 2006 Dec; 17(6):390-5. PubMed ID: 17168923
[TBL] [Abstract][Full Text] [Related]
20. Cytological distinction between clear cell carcinoma and yolk sac tumor of the ovary.
Kuwashima Y; Uehara T; Kurosumi M; Era H; Sano Y; Takahashi M; Shiromizu K; Matsuzawa M; Kishi K
Eur J Gynaecol Oncol; 1996; 17(5):345-50. PubMed ID: 8933827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
